Abstract:DDX3X is an RNA helicase with many functions in RNA metabolism such as mRNA translation, alternative pre-mRNA splicing and mRNA stability, but also plays a role as a regulator of transcription as well as in the Wnt/beta-catenin- and Nf-κB signaling pathways. The gene encoding DDX3X is located on the X-chromosome, but escapes X-inactivation. Hence females have two active copies and males only one. However, the Y chromosome contains the gene for the male DDX3 homologue, called DDX3Y , which has a very high sequence similarity and functional redundancy with DDX3X, but shows a more restricted protein expression pattern than DDX3X. High throughput sequencing of germinal center (GC)-derived B-cell malignancies such as Burkitt Lymphoma (BL) and Diffuse large B-cell lymphoma (DLBCL) samples showed a high frequency of loss-of-function (LOF) mutations in the DDX3X gene revealing several features that distinguish this gene from others. First, DDX3X mutations occur with high frequency particularly in those GC-derived B-cell lymphomas that also show translocations of the c-MYC proto-oncogene, which occurs in almost all BL and a subset of DLBCL. Second, DDX3X LOF mutations occur almost exclusively in males and is very rarely found in females. Third, mutations in the male homologue DDX3Y have never been found in any type of malignancy. Studies with human primary GC B cells from male donors showed that a loss of DDX3X function helps the initial process of B-cell lymphomagenesis by buffering the proteotoxic stress induced by c-MYC activation. However, full lymphomagenesis requires DDX3 activity since an upregulation of DDX3Y expression is invariably found in GC derived B-cell lymphoma with DDX3X LOF mutation. Other studies with male transgenic mice that lack Ddx3x , but constitutively express activated c-Myc transgenes in B cells and are therefore prone to develop B-cell malignancies, also showed upregulation of the DDX3Y protein expression during the process of lymphomagenesis. Since DDX3Y is not expressed in normal human cells, these data suggest that DDX3Y may represent a new cancer cell specific target to develop adjuvant therapies for male patients with BL and DLBCL and LOF mutations in the DDX3X gene.

A role for a DEAD box RNA helicase in natural killer cells

The DEAD box RNA helicase DDX3X is required in natural killer cells

The RNA helicase DHX15 is a critical regulator of natural killer-cell homeostasis and functions

The DEAD-box Helicase DDX56 is a Conserved Stemness Regulator in Normal and Cancer Stem Cells.

Histone Demethylases UTX and JMJD3 Are Required for NKT Cell Development in Mice

DDX3X: structure, physiologic functions and cancer

The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma

Multifunctional role of DEAD-box helicase 41 in innate immunity, hematopoiesis and disease

A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation

DDX41: exploring the roles of a versatile helicase

Post-transcriptional cross- and auto-regulation buffer expression of the human RNA helicases DDX3X and DDX3Y

NMR characterization of RNA binding property of the DEAD-box RNA helicase DDX3X and its implications for helicase activity

Multiple functions of DDX3 RNA helicase in gene regulation, tumorigenesis, and viral infection

The putative RNA helicase DDX1 associates with the nuclear RNA exosome and modulates RNA/DNA hybrids (R-loops)

DDX20: A Multifunctional Complex Protein

DDX3X Coordinates Host Defense Against Influenza Virus by Activating the NLRP3 Inflammasome and Type I Interferon Response

The DEAD Box RNA Helicase Ddx39ab is Essential for Myocyte and Lens Development in Zebrafish

The DEAD-Box RNA Helicase DDX3 Interacts with NF-κB Subunit p65 and Suppresses p65-Mediated Transcription

DEAD/H-Box Helicases in Immunity, Inflammation, Cell Differentiation, and Cell Death and Disease

Caspase-Dependent Cleavage of DDX21 Suppresses Host Innate Immunity

RNA helicase DDX3X modulates herpes simplex virus 1 nuclear egress